share_log

榮昌生物：董事會召開日期

REMEGEN: DATE OF BOARD MEETING

Hong Kong Stock Exchange ·  Aug 6 04:33
Summary by Moomoo AI
荣昌生物製藥（煙台）股份有限公司（「荣昌生物」）將於2024年8月16日召開董事會會議，主要目的是考慮及批准公司及其附屬公司截至2024年6月30日止六個月的中期業績報告及其刊發。該會議將由董事長兼執行董事王威東先生主持，並有其他執行董事和獨立非執行董事參與。會議的召開將有助於投資者了解公司的最新財務狀況和業務表現。
荣昌生物製藥（煙台）股份有限公司（「荣昌生物」）將於2024年8月16日召開董事會會議，主要目的是考慮及批准公司及其附屬公司截至2024年6月30日止六個月的中期業績報告及其刊發。該會議將由董事長兼執行董事王威東先生主持，並有其他執行董事和獨立非執行董事參與。會議的召開將有助於投資者了解公司的最新財務狀況和業務表現。
Rongchang Biopharmaceutical (Yantai) Co., Ltd. will hold a board of directors meeting on August 16, 2024, mainly to consider and approve the interim performance report of the company and its subsidiaries for the six months ended June 30, 2024, as well as its publication. The meeting will be chaired by Chairman and Executive Director Mr. Wang Weidong, with the participation of other executive directors and independent non-executive directors. The convening of the meeting will help investors understand the latest financial condition and business performance of the company.
Rongchang Biopharmaceutical (Yantai) Co., Ltd. will hold a board of directors meeting on August 16, 2024, mainly to consider and approve the interim performance report of the company and its subsidiaries for the six months ended June 30, 2024, as well as its publication. The meeting will be chaired by Chairman and Executive Director Mr. Wang Weidong, with the participation of other executive directors and independent non-executive directors. The convening of the meeting will help investors understand the latest financial condition and business performance of the company.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more